Molecular docking studies of phytochemicals from Terminalia chebula for identification of potential multi-target inhibitors of SARS-CoV-2 proteins

BACKGROUND: The COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a global pandemic claiming more than 6 million lives worldwide as of 16 March 2022. Till date, no medicine has been developed which is proved to have 100% efficiency in combating against th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarkar, Arkaniva, Agarwal, Rushali, Bandyopadhyay, Boudhayan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847108/
https://www.ncbi.nlm.nih.gov/pubmed/35185301
http://dx.doi.org/10.1016/j.jaim.2022.100557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847108/
https://www.ncbi.nlm.nih.gov/pubmed/35185301
http://dx.doi.org/10.1016/j.jaim.2022.100557

Ejemplares similares